Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

- PMLiVE

Random42 celebrates at Cannes Corporate 2017

Wins gold dolphin award for Defending LIfe: The Immune Ecosystem

- PMLiVE

Shire’s gene therapy candidate receives orphan drug status in the US

Investigational factor VIII treatment SHP654 is being developed for haemophilia

- PMLiVE

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

US advisors recommend GSK's shingle vaccine be used instead of Merck's rival product

- PMLiVE

McCann Health expands its Manchester footprint

Complete Medical Communications and Complete HealthVizion are set to double their capacity in the city

Roche Basel Switzerland

Roche biggest pharma R&D spender in PwC survey

Pharma giant on track to spend 21.9% of its total revenue on research this year

- PMLiVE

Lilly mulls divestment of its animal health operations

Pharma firm is due to make a final decision on Elanco in 2018

- PMLiVE

Alexion’s Soliris gets US approval for myasthenia gravis

New neurology indication could contribute $1.2bn to sales, says analysts

- PMLiVE

Gilead wins European approval for triple hep C combination Vosevi

The treatment brings together sofosbuvir, velpatasvir and voxilaprevir

Silence Therapeutics appoints Dr Annalisa Jenkins as non-executive chair

The Dimension Therapeutics CEO succeeds Dr Stephen Parker, who becomes a non-executive director

- PMLiVE

MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team

She joins the PR firm from MorphoSys, where she was senior VP

- PMLiVE

Positive disruption in business intelligence

A drug launch strategy

- PMLiVE

Change in the pharma industry is inevitable

But successul change isn't

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links